PAK6 promotes neuronal autophagy by regulating TFEB nuclear translocation.

Francesco Agostini,Rossella Agostinis,Martina Di Rocco,Sandro Montefusco,Giulia Tombesi,Lucia Iannotta,Susanna Cogo,Federica De Lazzari,Isabella Tessari,Laura Civiero,Evy Lobbestael,Veerle Baekelandt,Gabriele Sales,Diego Luis Medina,Xiaomeng Zhang,Elizabeth Hinde,Simone Martinelli,Marco Bisaglia,Nicoletta Plotegher,Elisa Greggio
DOI: https://doi.org/10.1101/2024.06.05.597537
2024-06-06
Abstract:Autophagy is a highly conserved homeostatic process essential for the bulk degradation of cytoplasmic components and aggregated proteins. Multiple evidence indicates that impairment of (macro)autophagy leads to neurodegeneration, such as Parkinson disease (PD). Our previous work showed that p21 activated kinase 6 (PAK6) interacts with the PD-associated leucine-rich repeat kinase (LRRK2) to promote neurite outgrowth in the mouse striatum; still the function of PAK6 in the brain is largely unknown. Here, we found that downregulation of neuronal but not glial , the homolog of PAK6, impairs autophagy-lysosomal function. PAK6 overexpression in cells and in increases transcription factor EB (TFEB) nuclear translocation in a kinase activity-dependent manner. Mechanistically, PAK6 forms a complex with TFEB to regulate its nuclear localization in a manner dependent on phosphorylation of and binding to 14-3-3 proteins and phosphorylation of TFEB at S467. In line with its ability to promote neuronal autophagy, downregulation exacerbates alpha-synuclein toxicity in dopaminergic neurons. Moreover, PAK6 overexpression in the of mutant LRRK2 mice reduces the burden of phosphorylated alpha-synuclein in dopaminergic neurons. Altogether, our study uncovers a novel role of PAK6 as a positive regulator of autophagy via TFEB and suggests that modulating its activity may represent a way to selectively turn on autophagy in neurons, with implications for the treatment of neurodegenerative disorders.
Neuroscience
What problem does this paper attempt to address?